Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$149K Buy
8,056
+503
+7% +$10K ﹤0.01% 1144
2026
Q1
$142K Buy
7,553
+6,363
+535% +$120K ﹤0.01% 1062
2025
Q4
$18.6K Buy
1,190
+550
+86% +$8.16K ﹤0.01% 1735
2025
Q3
$8.48K Sell
640
-207
-24% -$2.67K ﹤0.01% 1976
2025
Q2
$10.5K Buy
847
+641
+311% +$8.07K ﹤0.01% 1876
2025
Q1
$3.14K Sell
206
-218
-51% -$3.26K ﹤0.01% 1820
2024
Q4
$6.19K Buy
424
+41
+11% +$640 ﹤0.01% 1681
2024
Q3
$6.12K Hold
383
﹤0.01% 1687
2024
Q2
$7.28K Buy
+383
New +$7.18K ﹤0.01% 1610

Other funds holding NOV

Clearstead Advisors's NOV Position: Q2 2026 in Review

Clearstead Advisors increased its NOV (NOV) stake by 6.7% in Q2 2026, buying an estimated $10K and bringing the position to 8,056 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #1144.

Clearstead Advisors first reported a position in NOV in Q2 2024 and has held it in 9 quarters since. 488 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Clearstead Advisors held 8,056 shares of NOV worth $149K as of Q2 2026.
  • Clearstead Advisors bought 503 NOV shares in Q2 2026, an estimated $10K.
  • NOV made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1144 holding.
  • Clearstead Advisors first reported a position in NOV in Q2 2024 and has held it in 9 quarters since.
  • 488 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.